SIC inactivates antibacterial peptides 4 DNA sequencing-Polymerase chain reaction (PCR) was used to amplify the sic genes from the S. pyogenes strains U15, U17, AP12 and W38. For serotype M1 strains (U15 and U17), primers were constructed corresponding to the nucleotide s e q u e n c e s t a r t i n g 7 2 b a s e p a i r s u p s t r e a m (ACCTTTACTAATAATCGTCTTTGTTTTATAATGA) and 179 base pairs downstream (ATCTTTCTCGGACTCAGATAGTCCATAGC) of the coding sequence for sic in the AP1 strain (7) . For serotype M12 (AP12) and M55 (W38)
strains, a forward primer (CATTAACGAAATAATTTATTAAGGAGAG) corresponding to a region upstream the coding sequence of sic from AP1, and a reverse primer (CCAAEGATAGTCACCAGCAATTCAGG) corresponding to a region downstream the coding sequence of the distantly related sic from M12 and 55
strains (8) . The PCR products were purified with a High Pure PCR purification kit (Roche Diagnostics), and used as templates in sequencing reactions using a ABI PRISM ® BigDye™ dideoxy terminator kit (BigDye terminator version 3.0 cycle sequencing Ready Reaction, Applied Biosystems), according to the manufacturer's instructions.
Proteins, peptides, antibodies and radiolabelling-Recombinant M1 protein was prepared as described previously (17) , α -defensin (HNP-1),
ACYCRIPACIAGERRYGTCIYQGRLWAFCC (Mw 3442) was purchased from
Sigma, and LL-37, LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES (Mw 4492) was synthesized by Innovagen AB, Lund, Sweden. The peptide GCP28, GCPRDIPTNSPELEETLTHTITKLNAEN, based on a sequence in human kininogen has been described previously (18) and was a kind gift from Dr. Heiko Herwald, Lund University, Lund, Sweden. Mouse monoclonal α-defensin antibodies were from Bachem AG, and rabbit polyclonal LL-37 antibodies were from Innovagen AB.
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Generation of a sic mutant in Streptococcus pyogenes and Northern blotting-
To inactivate the gene encoding protein SIC, AP1 bacteria were subjected to an allelic replacement mutagenesis strategy. A fragment of the up-stream sph and of the downstream IS1562 was amplified from AP1 by PCR as described (20) using synthetic oligonucleotides hybridizing with nucleotides 486-512 and 1559-1533 in (21) and 516-539 and 1614-1641 in (22) . The oligonucleotides had sites for restriction enzymes which were used to clone the sph product into multiple cloning site I (MCSI) of plasmid pFW13 (23) and the IS1562 product into MCSII to generate pFW13sic -.
20 µg of pFW13sic -was electroporated as described (24) into AP1 bacteria.
Recombinants were selected on plates containing 150 µg/ml kanamycin. One transformant (SIC -) was obtained and growth media from this strain was incubated with 6% trichloroacetic acid (TCA) for 30 min on ice followed by centrifugation at 15 000 x g (4°C for 20 min). Precipitated material was analysed for SIC content using polyclonal anti-SIC antibodies in Western blot experiments.
Total RNA from the AP1 and SIC -strains was isolated at early logarithmic (A 620 -0.3), late logarithmic (A 620 -0.6), or early stationary phase (A 620 -0.8) as described previously (20) . Northern blotting was performed as described (20) using a probe generated with primers hybridizing to sic (1-28, 912-889 in (7)). and LL-37, were used in this investigation. These peptides have broad antibacterial activity against both Gram-positive and Gram-negative bacteria. α-defensin (HNP -1) is found in the azurophilic granules of human neutrophils, but analogues to neutrophil α-defensins are produced also by intestinal Paneth cells (26, 27) . LL-37 is produced by neutrophils and epithelial cells. α-defensin and LL-37 are both found in extracellular fluids, including wound fluid, and the two peptides act synergistically on target bacteria (28) . In S. pyogenes, the sic gene is part of the so-called mga regulon and like the other genes of this regulon sic is expressed at an early growth phase (7),
Animal experiments-
suggesting that SIC will be secreted as soon as S. pyogenes bacteria carrying the sic gene start to grow on an epithelial surface. To investigate whether α-defensin and LL-37 have affinity for SIC, these peptides and a control peptide (GCP28) based on a sequence in H-kininogen (18) , were applied to Immobilon filters which were probed with 125 I-labelled SIC (if not indicated otherwise SIC is from the M1 strain AP1). Figure 1A shows that SIC interacts with the antibacterial peptides, an observation which was confirmed also by experiments where SIC and M1 protein were applied to plastic wells, followed by the addition of α-defensin or LL-37 and antibodies to the peptides. M1 protein was chosen as a control. It was isolated from the same strain of S. pyogenes (AP1) as SIC (7), and although the protein is predominantly associated with the cell wall, it is also released from the bacterial surface by proteolytic cleavage In the experiments summarized in Figure 1B , α-defensin and LL-37 showed affinity for SIC, whereas the interaction with M1 protein was at background level.
Next we investigated the antibacterial effect of α-defensin and LL-37 on the AP1 strain. In these experiments the bacteria were washed and resuspended in buffer prior to the addition of the peptides to exclude that SIC was present during the incubation period. As shown in the left panel of Figure 2 , the peptides killed the peptide LL-37, the mutant strain SIC -was found to be as sensitive to LL-37 as the wild-type strain AP1 (see Fig. 2, left panel) . In a series of experiments we then investigated whether SIC produced by growing M1 bacteria, could protect the organisms against LL-37 (these experiments required substantial amounts of antibacterial peptide and only LL-37 was tested). The wild-type AP1 strain and the mutant strain SIC -were grown to early logarithmic growth phase where the concentration of SIC produced by AP1 bacteria was 0.85 µg/ml growth medium as determined by ELISA (Fig. 3C ). The secretion of protein SIC by the mutant SIC -was below the detection level (Fig. 3C) . At this point different amounts of LL-37 were added. As shown in Fig. 3D , SIC -bacteria were more sensitive to LL-37 as compared to the SIC producing strain AP1. The concentration of LL-37 required to kill 50% of SIC -bacteria in these experiments was 22.3 µM, while at this concentration only 20% of the wild-type bacteria were killed. Lower concentrations of LL-37 killed 20%
of SIC -bacteria but the AP1 strain was unaffected. The amount of protein SIC produced was determined at different time points during growth. While the concentration of SIC produced by AP1 bacteria in this experimental system, reached its maximum (4.75 µg/ml) at early stationary phase (6 h), the amount of protein SIC in the growth medium of the mutant strain SIC -was below the level of detection (Fig.   3C ). The results suggest that SIC secretion provides protection against antibacterial peptides already at an initial stage of infection.
As mentioned, SIC variants are produced by S. pyogenes strains of M serotypes 1, 12, 55, and 57 (7, 8) . Using the same isolation protocol as for SIC from M1 bacteria (7), SIC was purified from the growth medium of M12 and M55 organisms. Analogous to the M1 strain (7), the M12 and M55 strains produced 10-15
µg SIC/ml growth medium when grown to stationary phase. Protein SIC was also purified from two additional strains of the M1 serotype, U15 and U17. The purified variants shown in Fig. 4A were tested for their ability to interfere with the antibacterial activity of α-defensin and LL-37. As shown in Fig. 4B , all SIC variants, but not M1 protein, blocked the activity of the peptides. The inhibition curves show that SICM1 is 5-100 times more potent in this respect than the protein SIC variants from the M12 and M55 strains. To investigate a possible molecular basis for this difference in inhibitory activity, sequencing of the genes encoding the SIC variants was performed. As mentioned, there is a high degree of variation among sic genes from different strains of the M1 serotype (10), and nearly 300 alleles are known. The amino acid sequences derived from the obtained sic sequences were compared to that of protein SIC from the M1 strain AP1 (GenBank Accession number X92968 (7)). A deletion of a region of 29 amino acid residues in SIC from U15, and some shorter insertions and single amino acid substitutions were observed within the M1 variants (Fig. 5A) . However, the sic genes of the M12 and M55 strains are clearly more different, as compared to the sic genes of the M1 strains (not shown). The sequence of SICM12 was found to be identical to a recently published sequence (GenBank Accession number AJ300679 (30)), and as demonstrated in are all known to be associated with poststreptococcal glomerulonephritis, suggesting a role for SIC in this condition (7, 8) . Moreover, the fact that M1 strains dominate in cases of invasive disease (6) and that SICM1 is the most potent inhibitor of α-defensin and LL-37, support the notion that the interference of SIC with antibacterial peptides could facilitate S. pyogenes invasion through mucosal and skin barriers.
Over the past 10-20 years research in many laboratories has firmly established showed that an isogenic M1 mutant strain in which the sic gene had been inactivated, was significantly less efficient in colonizing the throat of mice as compared to the wild-type strain. Here we find, using a mouse model of subcutanous infection, that the mutant strain SIC -is significantly attenuated in virulence compared to the wild-type AP1 strain (Table 1) . Combined these data suggest that SIC promotes early stages of infection by inactivating antibacterial peptides. The results of the present work may also explain the unique variability of the sic gene and the fact that the M1 serotype is the serotype most frequently connected with invasive S. pyogenes infection. 
